Navigation Links
AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy

is Conference, Denver, Colorado, November 2-5, 2006, indicated that dosing of Moli1901 for 5 consecutive days by the inhalation route improved lung function in a dose-dependent manner.

About AOP Orphan

AOP Orphan Pharmaceuticals AG is a privately held corporation founded in Vienna in 1997. The company is dedicated to developing, marketing and distributing medicines in niche indications on a Pan-European level with special focus on Central and Eastern Europe, Middle East and Southern Asia.

About Lantibio

Lantibio, Inc. is a development pharmaceutical company focused on discovery, development, and marketing of products for the treatment of ocular disease and serious respiratory conditions. Lantibio's lead product, Moli1901 holds an IND in CF in the US as well as Orphan Drug status in that indication.

This press release might contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from AOP Orphan's and/or Lantibio's expectations and projections. Risks and uncertainties include success of clinical trials for AOP Orphan's and/or Lantibio's products, intellectual property risks, need for additional financing or capital, ability to develop and successfully commercialize our products, ability to enter into licensing agreements, and the ability of the competition to render AOP Orphan's and/or Lantibio's product candidates or technologies obsolete or noncompetitive. AOP Orphan and Lantibio assume no obligation to update any forward-looking statements as a result of new information or future events or developments, except as required by law.

CONTACT: Rudolf S. Widmann, CEO of AOP Orphan Pharmaceuticals, +43 1 50372 44, or ; Luis Molina, President-CEO ofLantibio, +1-919-960-0217, or ; Copy Editing
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
3. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
(Date:12/1/2008)...e-FirstCall/ -- GeoVax Labs, Inc.,(OTC Bulletin B...y developing,human vaccines for diseases caused b...infectious agents, announced today that the launch...lace in twelve sites across North and South Americ...th The National Institutes of,Health (NIH), and t...
(Date:11/28/2008)...ewswire-FirstCall/ -- Eli Lilly and Company,(NYSE...Application (sNDA) from,the U.S. Food and Drug Ad...),for the management of chronic pain. Lilly plans... 2009, adding data from a recently completed posit...nee. , The decision does not affect duloxet...
(Date:11/25/2008)...ove recovery , , Audio and Web Video Resour...ayo Clinic News Blog. Please see the bottom of thi...Minn., Nov. 25 A Mayo C...n,t think they,re having a stroke -- and as a resu...n worsens. The findings appear in the current issu...
(Date:11/25/2008)... Pharmacyclics, Inc.,(N...as completed a Phase 1,clinical trial with PCI-27...lecule Factor VIIa inhibitor. The trial was conduc...e the safety and pharmacologic effect of,PCI-2748...n a linear dose,response in the International Nor...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Research Attributes Lack of HIV AIDS Vaccine to Use of Chimpanzees 3225 1Research Attributes Lack of HIV AIDS Vaccine to Use of Chimpanzees 3225 2Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer 5246 1Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer 5246 2Surface tension drives segregation within cell mixtures 5244 1Surface tension drives segregation within cell mixtures 5244 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3223 1Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3223 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3223 3
...ase 1 Colorectal and Prostate Cancer,Trials To Be ...RANCISCO, Calif., May 23, 2007 /PRNewswire-FirstCa...ceutical company,focused on oncology, today announ...the Company,s lead product candidate, in patients,...ed in a poster,session at the 43rd Annual Meeting ...
...07 /PRNewswire-FirstCall/ -- Vical,Incorporated to...study, a DNA vaccine formulated with the company,s...needle-free injection,yielded significantly higher...ne delivered by needle and syringe. In a,separate ...of,unformulated vaccine yielded comparable improve...
Other Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 3Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 4Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA,Vaccine Performance; Yields Antibody Responses Comparable to,Electroporation Without Tolerability Issues 2Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA,Vaccine Performance; Yields Antibody Responses Comparable to,Electroporation Without Tolerability Issues 3Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA,Vaccine Performance; Yields Antibody Responses Comparable to,Electroporation Without Tolerability Issues 4
(Date:12/2/2008)...a leading provider of onsite health services and t...e, the athletic products company, has selected Mar...te health clinics and to provide health services t... Burlington, VT (PRWEB) Decem... of onsite employee health services and technology...
(Date:12/2/2008)...nal Day of Disabled Persons is recognized on Dec. ...g boy born with backwards pointing feet. After fre...ospital docked in Liberia, Benedict,s feet are cor...children his age. High resolution photos and vid...g , Garden Valley, TX (V...
(Date:12/2/2008)...unces that the SouthEast Alaska Regional Health Co...the Rhapsody™ Integration Engine to help the...armacy, laboratory and business programs communica...tivity to statewide systems such as VacTrAK (the S...an MIS and clinical documentation tool used by sub...
(Date:12/2/2008)...orola, Inc. (NYSE: MOT ),announced today that i...enable,three hospitals managed by leading Europea...to deliver voice, data and video services. The inn... broadband infrastructure to support,multimedia s..., eliminating,the need for additional cabling or ...
Breaking Medicine News(10 mins):Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 3Health News:Mercy Ships Recognizes International Day of Disabled Persons 2Health News:Mercy Ships Recognizes International Day of Disabled Persons 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 2Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 3
...al cardiologist at the Washington Hospital Center ...ergy) to restore blood flow in blocked arteries. /...eople suffering from advanced diabetes as it leads...ns such as amputation. People with diabetes and e...
...s of Kryptiq's Care Manager Diabetes Module at the...ems Society (HIMSS) conference. // This module ...nts who benefited. The one year study showed that ...holesterol and blood pressure levels. Providence M...
...y men contact in Hong Kong has been in a way respo... a latest report. // Government health officials ...vember 2005, had HIV with similar gene sequencing,...st reported. The discovery was made when all the ...
...d be as simple as swallowing a spongy pill with a ...ts of Cambridge University researchers // that can... UK every year. It is the ninth most commonly occu...he windpipe, the pill is pulled out, gently scrapi...
Other Medicine News:Health News:Laser Used To Clear Blocked Arteries Preventing Amputation, 2Health News:Kryptiq Care Manager Diabetes Module Effective In Managing Diabetes 2
Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 5-8; contains 1 bottle each of 20 nm and 40 nm Naked Gold
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 12 OD
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 50 OD
Colloidal Gold Conjugated, Goat anti-human IgM (Mu Chain) - 12 OD
Medicine Products: